Navigation Links
ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Date:4/30/2009

CONSHOHOCKEN, Pa., April 30 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical services and trial management technologies for the biopharmaceutical industry announced that it has been selected along with its client Genentech, Inc as the winner of the Bio-IT World Best Practice Award for it's Clinical Trial Portal solution. Winners were selected from 72 submissions in 7 categories by a peer reviewed panel of 14 expert judges. The ePharmaSolutions Clinical Trial Portal Solution won in the Clinical Trials Management category.

"We are absolutely thrilled that our application is recognized as the most innovative clinical trial management solution by such a distinguished panel of judges," stated Lance Converse, Founder and CEO of ePharmaSolutions. "We have worked exceptionally hard to develop solutions that help solve some of the industries biggest causes of study delays. This award validates our mission and strategy to provide to the industry with best in class solutions that facilitates ongoing communication and collaboration between all of the stakeholders in the clinical trial process," added Converse.

The Clinical Trial Portal was developed to provide pharmaceutical companies with a common technology platform to streamline and accelerate site selection, activation, training, patient recruitment and communication. In addition, the Clinical Trial Portal uses a federated user identity management model that provides users with one set of credentials across all sponsors to help reduce the amount of userIDs and passcodes that are typically required in this industry. The Clinical Trial Portal currently hosts 143,000 active clinical research users from 107 countries for the top 20 pharmaceutical companies in the world.

"To be selected along side such companies as Wyeth, GSK, Merck, Abbott and AstraZeneca is truly an honor," said Enrico DePaolis, President & Chief Operating Officer for ePharmaSo
'/>"/>

SOURCE ePharmaSolutions
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--Rem...eam-likefoamthatstopsseverebleeding,wonfirstprizea...heGlobalSecurityChallenge2009,companyofficialsanno...maroundtheworld,Remedium,steampitchedtheirinventio...hoolofBusiness. ,, Remedium( www.remediumtechno...
(Date:11/25/2009)...BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosci...antithromboticaptamerswithactivecontrolagents,anno...entingatthePiperJaffray21stAnnualHealthCareConfere...presentationwillbegivenat1:10pm(EST)onTuesday,Dece...ewithemphasisontheleaddevelopmentprogram,theantico...
(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannoun...alogue: ,, UnitedStatesDentalDevicesMarketAnal...nker.com/p0158733/United-States-Dental-Devices-Mar...tedStatesDentalDevicesMarketAnalysisandForecaststo...sourceforin-depthinformationanddatarelatingtotheUS...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Patients in Europe benefit from new radiation therapy 10575 1Patients in Europe benefit from new radiation therapy 10575 2Patients in Europe benefit from new radiation therapy 10575 3Is There a Bad Driver Gene 3F 60335 1Is There a Bad Driver Gene 3F 60335 2Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 1Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 2Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 3Tamiflu Resistant Swine Flu Passed Person to Person in U S 60332 4
... 17, 2007 - GTx, Inc. (NASDAQ:,GTXI) announced tod...tarine(TM) clinical trial of 60 elderly men and 60...ucose levels were reduced and,insulin resistance w... of Ostarine compared to baseline. These observati...ediabetic subjects., Data from the Phase II clinic...
...17, 2007,/PRNewswire-FirstCall/ -- Cell Genesys, I...reviously conducted Phase 2 clinical trials,of GVA... antibody,responses in patients with advanced pros... cell-based immunotherapy induces,antibody respons...,antigens, including some not previously known to ...
Other Medicine Technology:GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial 2GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial 3GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial 4Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 2Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 3Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 4
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBayAreaAirQualityManagement... the Air Alert forThursday,November26,20...hersolidfuel,bothindoorsandoutdoors. ,, "Cold,s...rrow,"saidJackBroadbent,executiveofficeroftheAirDi...lthoftheirneighborsandfellowcommunitymembersthisTh...
(Date:11/25/2009)...e blood pressure? This simple question has been t...Stress-related gene Modulates High Blood Pressure ...e? This simple question has been the focus of int...s for the first time established a link between a ...onse to stress in mice as well as humans. The stud...
(Date:11/25/2009)...ed by neurological symptoms, study finds , ...logical side effects are among the potential probl...cer who were treated with cisplatin-based chemothe...ed 1,409 Norwegian men treated for unilateral test...in a follow-up survey conducted from 1998 to 2002....
(Date:11/25/2009)... A cancer vaccine carried into the body on a caref...irst to successfully eliminate tumors in mammals, ...e Translational Medicine . , The new approach, p...ard University, uses plastic disks impregnated wit...skin to reprogram the mammalian immune system to a...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of ...agnostic imaging equipment, now offering a total s...ing options, service and installation with acquisi...chnologies of California) , ...de Imaging Services is proud to announce its acqui...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...skAnalyzer Incorporates Johns Hopkins ACG System f...ce Management and Rate Adjustment , , BIRMINGHAM,...ounced the launch of its new Medicare risk adjustm... the Centers for Medicare and Medicaid Services Hi...
... Sixteen QHR hospital client...million in February. The payments - ranging from ...ospital clients participating in a unique and inno...am, hospital groups that experience less than proj...
...he cadherin superfamily has a correlate relationsh...It has been suggested that, unlike E-cadherin, N-c...noma cells. To explore clinical pathological signi...tected the expression of E-cadherin and N-cadherin...
...oughly 100,000 Swedes are under treatment with the...ng sensitivity to Waran, which makes the initiatio...rhaging and clotting. Now researchers at Uppsala... England Journal of Medicine . , Some 20 researc...
...RCHASE, N.Y., Feb. 19 The PepsiCo Foundation toda... the Children to help ensure the survival and well...adesh, which together are home to 40 percent of th...on, Save the Children will work towards decreasing...
...N DIEGO, Feb. 19 Cardium Therapeutics (NYSE Alter...ompliance plan submitted on January 23, 2009 has b...y the American Stock Exchange). , , (Logo: ht...rrent listing exchange indicating that the company...
Other Medicine News:Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 2Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 3Health News:QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospital Clients 2Health News:Knowledge of genetics improves uncertain medication 2Health News:PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations 2Health News:PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations 3Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 2Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 3Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 4Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 5
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: